Giulio Cataldo
Papers
1
Total Citations
5
H-Index
1
About
Giulio Cataldo is a surgical oncologist whose research focuses on optimizing outcomes for patients with colorectal cancer, particularly through the integration of neoadjuvant chemotherapy. His most cited work, "Impact of neoadjuvant chemotherapy for locally advanced colon cancer on postoperative complications" (2023, 5 citations), addresses a critical question in modern oncology: whether preoperative chemotherapy increases surgical risks. By demonstrating that neoadjuvant treatment does not significantly elevate postoperative complications, Cataldo provides crucial evidence supporting the safety of this approach for locally advanced colon cancer. This finding has implications for expanding treatment paradigms beyond rectal cancer, where neoadjuvant therapy is standard. Cataldo’s research bridges surgical technique and oncologic strategy, helping to refine protocols that balance tumor response with patient recovery. His work contributes to the growing body of evidence that neoadjuvant chemotherapy can be safely employed in colon cancer, potentially improving long-term outcomes without compromising surgical safety. For students and researchers, Cataldo’s studies underscore the importance of rigorous clinical investigation in translating therapeutic advances into practice.
Research Focus
Key Achievements
Top Papers
- 1